title: HPV 6, 11, 16, 18 vaccine in men. Inadequate assessment.
abstract: In a trial including 4065 men aged 16 to 26 years, HPV 6, 11, 16, 18 vaccination reduced the incidence of anogenital warts, but the preventive effect on cancer remains to be demonstrated.
mesh_terms: D000293:Adolescent; D000328:Adult; D019317:Evidence-Based Medicine; D052140:Human papillomavirus 11 / Q000276:immunology*; D052162:Human papillomavirus 16 / Q000276:immunology*; D052161:Human papillomavirus 18 / Q000276:immunology*; D052163:Human papillomavirus 6 / Q000276:immunology*; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D054526:Men's Health; D009369:Neoplasms / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D014611:Vaccination; D055815:Young Adult
chemical_list: D053918:Papillomavirus Vaccines